IMMUNOME - ENTERS AMENDMENT NO. 4 TO LICENSE AGREEMENT WITH BRISTOL-MYERS SQUIBB COMPANY ON OCT 2, 2026 - SEC FILING

Reuters · 2d ago

Please log in to view news